BioHarvest Sciences Inc. Common Stock (BHST) vs The Procter & Gamble Company (PG)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BHST | PG | |
|---|---|---|
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Packaged Foods | Household & Personal Products |
| Size band | NANO | MEGA |
| Listing | Nasdaq GM | NYSE |
| Country | Canada | United States |
| Theme | packaged-foods | household-products |
| Price and returns | ||
| Last close | $1.68 | $159.92 |
| Return · 1 week | −6.67% | +2.09% |
| Return · 1 month | +15.86% | +7.31% |
| Return · 3 months | −17.65% | +7.42% |
| Return · year to date | −67.75% | +14.44% |
| Return · 1 year | −84.69% | +6.94% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −86.23% | −4.38% |
| 52-week high | $12.20 | $167.25 |
| 52-week low | $1.37 | $137.62 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $38.08M | $370.66B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $41.24K | $1.29B |
| Employees | 89 | 104,000 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 24.07× |
| Price to earnings · forward | n/a (negative forward earnings) | 21.56× |
| Price to sales | 1.10× | 4.26× |
| Price to book | 1.97× | 6.94× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 16.02× |
| Enterprise value to revenue | 1.08× | 4.56× |
| PEG ratio | — | 4.08 |
| Earnings per share · trailing | -0.51 | 6.62 |
| Profitability | ||
| Gross margin | 58.95% | 50.18% |
| Operating margin | −28.37% | 22.08% |
| Profit margin | −31.21% | 18.10% |
| Return on equity | −142.50% | 30.29% |
| Return on assets | −11.02% | 10.72% |
| Growth | ||
| Revenue growth | +3.80% | +1.50% |
| Earnings growth | — | −15.50% |
| Balance sheet and payout | ||
| Debt / equity (%) | 79.41 | 64.49 |
| Current ratio | 2.24 | 0.68 |
| Dividend yield | 0.00% | 2.73% |
| Payout ratio | — | 64.33% |
| Trend and volatility | ||
| RSI · 14 | 49.75 | 61.34 |
| ADX · 14 | 14.22 | 34.41 |
| 50-day average | $1.73 | $148.67 |
| 200-day average | $3.31 | $148.61 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 10.19% | 2.07% |
The full BHST analysis
Everything this table leaves out for BioHarvest Sciences Inc. Common Stock: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BHST argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BHST analysisThe full PG analysis
Everything this table leaves out for The Procter & Gamble Company: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the PG argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full PG analysis